Fungal Nail Infection: MOB015B Solution for Kids

We are studying a new topical solution for treating mild to moderate fungal infections of the nail in children aged 6 to 17. The goal is to see how well it works and how safe it is.

6-12 months 6-10 visits Efficacy phase (II)No Placebo Partially Remote Standard MedicinesDermatologyInfectious DiseasesPediatrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Terbinafin Moberg Pharma

Terbinafin Moberg Pharma is a medicine that treats fungal nail and skin infections like athlete's foot.

Terbinafina Moberg Pharma

Terbinafina Moberg Pharma is an antifungal medicine used to treat fungal skin infections like athlete's foot and nail fungus.

Terclara

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Terbinafine

Terbinafine is a substance that treats fungal infections of the skin and nails.

Terbinafine Hydrochloride

Terbinafine hydrochloride is a substance that treats fungal infections of the skin and nails.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Amykal

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Zealand University Hospital

Department of Dermatology

Roskilde, Denmark

Azienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi

Dipartimento di Medicina Specialista, Diagnostica e Sperimentale

Bologna, Italy

NZOZ Specjalistyczny Ośrodek Dermatologiczny DERMAL

NZOZ Specjalistyczny Ośrodek Dermatologiczny DERMAL S.C.

Białystok, Poland

Sponsor: Moberg Pharma AB (publ)

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.